Allergy tablets issued urgent recall over contamination risk – Health…

An urgent recall has been issued for widely-used allergy medication due to potential ‘life threatening’ problems. The antihistamine has been pulled from cabinets by the pharmaceutical producer over contamination issues.

New Jersey-based pharmaceutical company Rising Pharma Holdings Inc. initiated the recall on Saturday, July 18. The recall impacts 4 tons of 5-milligram cetirizine hydrochloride tablets, generally used to deal with seasonal allergic reactions and hives. Indian-based producer Unique Pharmaceutical Laboratories produced the medication, according to the Food and Drug Administration, experiences the Express.

The drug was distributed and bought across the United States. The cetirizine hydrochloride tablets might have been cross-contaminated with ranitidine, which is prescribed to deal with heartburn, acid indigestion and bitter abdomen, the businesses reported.

Ranitidine reduces the quantity of acid produced in the abdomen. According to the FDA’s web site, the issue was found when a pharmacy technician observed a pink dot on some tablets while counting them.

The cetirizine hydrochloride tablets under recall are packaged in bottles of 100. The affected bottles include the next info:

While no antagonistic reactions to the cetirizine hydrochloride tablets have been reported to date, sufferers with a hypersensitivity to ranitidine ingredients might expertise “serious adverse events”, the announcement warned.

Those with a sensitivity to ranitidine who devour the tablets risk struggling anaphylaxis.

Rising Pharma Holdings Inc. said: “Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.”

Anyone experiencing antagonistic reactions is inspired to report them to the FDA’s MedWatch Adverse Event Reporting program by finishing and submitting a report at www.fda.gov.